MXCT vs ROP
MaxCyte Inc (MXCT) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
MXCT currently screens at market cap $124.3M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the MXCT and ROP stock pages for the full models.
Not investment advice.